La cadena de opciones muestra datos clave de las opciones de acciones de Danaher a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Danaher..

Danaher (NYSE:DHR) Bolsa, Cadena de Opciones

Danaher

In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.

Long Ideas

News

Markets

Media

Trading Ideas

ATEN

FSLY

IESC

Jim Cramer analiza el rendimiento de varias acciones estadounidenses y comparte sus recomendaciones clave. ¿Cuáles destacan y cuáles evitar?

Cramer respalda NextEra Energy (NEE) y descarta otras acciones: ¿cuáles tienen más potencial?

Danaher Corp

DEUTSCHE EUROSHOP UNS/ADR by Deutsche Euroshop AG

Deutsche EuroShop AG

<p>Danaher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) has outperformed the market over the past 10 years by 2.96% on an annualized basis producing an average annual return of 12.55%. Currently, Danaher has a market capitalization of $133.67 billion. </p>
<p><strong>Buying $100 In DHR:</strong> If an investor had bought $100 of DHR stock 10 years ago, it would be worth <strong>$326.41</strong> today based on a price of $186.83 for DHR at the time of writing.</p>
<h3>Danaher's Performance Over Last 10 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1744925426_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


$100 Invested In Danaher 10 Years Ago Would Be Worth This Much Today

<p>U.S. major indices traded lower at midday Wednesday, pressured by sharp declines in tech and semiconductor stocks after Washington tightened chip <a href="https://www.benzinga.com/topic/china">export restrictions to China.</a></p>
<p>The U.S. government has barred <strong>Nvidia Corp.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) from selling its H20 chips to China — a move that could wipe out an estimated $5.5 billion from the company's projected quarterly revenue. Nvidia shares slid nearly 7%.</p>
<p>Other chipmakers also felt the heat. <strong>Advanced Micro Devices Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) dropped 6% as its MI308 chips fall under the new licensing requirements.</p>
<p>The<strong> iShares Semiconductor ETF</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOXX#NASDAQ">SOXX</a>) sank 3.4%, extending the sector&#8217;s losses. Adding to the drag, Dutch chip equipment giant <strong>ASML Holding N.V.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASML#NASDAQ">ASML</a>) missed quarterly revenue estimates, sending its shares down 5%.</p>
<p>On the macro front, March retail sales surprised to the upside, rising 1.4% month-over-month — topping forecasts of 1.3% and marking the strongest monthly <a href="https://www.benzinga.com/25/04/44837237/march-retail-sales-post-highest-surge-in-over-two-years-as-us-consumers-anticipate-tariff-jitters">gain since January 2023.</a></p>
<p>Meanwhile, the U.S. dollar saw renewed selling pressure, with the dollar index dipping back below 100. Treasury yields were little changed, with the 10-year yield holding steady near 4.33%.</p>
<p>Gold continued its stellar run, surging 2.5% to a fresh record high of $3,320 per ounce as demand for safe-haven assets remains robust.</p>
<p>In commodities, oil prices rebounded sharply, with WTI crude climbing 2% to $62 a barrel. <strong>Bitcoin</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) also edged up 1.3% to around $84,500.</p>
<p>All eyes are now on Fed Chair <strong>Jerome Powell</strong>, who is set to speak at the Economic Club of Chicago later this afternoon.</p>
<h3 class="wp-block-heading">Wednesday&#8217;s Performance In Major US Indices, ETFs</h3>
<p><figure class="wp-block-table is-style-stripes"><br />
<table>
<tbody>
<tr>
<td><strong>Major Indices </strong></td>
<td><strong>Price</strong></td>
<td><strong>Chg %</strong></td>
</tr>
<tr>
<td>Dow Jones</td>
<td>40,318.86</td>
<td>-0.1%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>1,872.38</td>
<td>-0.6%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,340.12</td>
<td>-1.0%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>18,501.22</td>
<td>-1.7%</td>
</tr>
</tbody>
</table>
<p><figcaption class="wp-element-caption"><em>Updated at 11:30 a.m. ET</em></figcaption></p></figure></p>
<p><strong>According to&nbsp;</strong><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1"><strong>Benzinga Pro</strong></a><strong>&nbsp;data:</strong></p>
<ul>
<li>The&nbsp;<strong>SPDR S&amp;P 500 ETF Trust</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) fell 0.9% to $532.68.</li>
<li>The&nbsp;<strong>SPDR Dow Jones Industrial Average</strong>&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) eased 0.1% to $403.09.</li>
<li>The tech-heavy&nbsp;<strong>Invesco QQQ Trust Series</strong>&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;tanked 1.7% to $450.31.</li>
<li>The&nbsp;<strong>iShares Russell 2000 ETF</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) fell 0.5% to $185.84.</li>
<li>The&nbsp;<strong>Energy</strong>&nbsp;<strong>Select Sector SPDR Fund</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) outperformed, up 1.1%; the&nbsp;<strong>Technology&nbsp;Select Sector SPDR Fund</strong>&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>) lagged, down 2.2%.</li>
</ul>
<h3 class="wp-block-heading">S&amp;P 500&#8217;s Top 5 Gainers On Wednesday</h3>
<p><figure class="wp-block-table is-style-stripes"><br />
<table>
<thead>
<tr>
<th>Company</th>
<th>% Change</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Abbott Laboratories</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABT#NYSE">ABT</a>)</td>
<td>5.39%</td>
</tr>
<tr>
<td><strong>United Airlines Holdings, Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UAL#NASDAQ">UAL</a>)</td>
<td>4.33%</td>
</tr>
<tr>
<td><strong>The Travelers Companies, Inc.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRV#NYSE">TRV</a>)</td>
<td>4.17%</td>
</tr>
<tr>
<td><strong>APA Corporation</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APA#NASDAQ">APA</a>)</td>
<td>3.92%</td>
</tr>
<tr>
<td><strong>The Mosaic Company</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOS#NYSE">MOS</a>)</td>
<td>3.84%</td>
</tr>
</tbody>
</table>
<p></p></figure></p>
<h3 class="wp-block-heading">S&amp;P 500&#8217;s Worst 5 Losers On Wednesday</h3>
<p><figure class="wp-block-table is-style-stripes"><br />
<table>
<thead>
<tr>
<th>Company</th>
<th>% Change</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>J.B. Hunt Transport Services, Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBHT#NASDAQ">JBHT</a>)</td>
<td>-8.40%</td>
</tr>
<tr>
<td><strong>NVIDIA Corporation</strong> </td>
<td>-6.81%</td>
</tr>
<tr>
<td><strong>Advanced Micro Devices, Inc.</strong></td>
<td>-5.81%</td>
</tr>
<tr>
<td><strong>KLA Corporation</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLAC#NASDAQ">KLAC</a>)</td>
<td>-4.77%</td>
</tr>
<tr>
<td><strong>The Interpublic Group of Companies, Inc.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IPG#NYSE">IPG</a>)</td>
<td>-4.71%</td>
</tr>
</tbody>
</table>
<p></p></figure></p>
<p><strong>Read now: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/25/04/44832771/the-ball-is-in-chinas-court-trump-says-as-white-house-awaits-beijings-call-china-needs-to-make-a-deal-with-us">&#8216;The Ball Is In China&#8217;s Court&#8217;: Trump Says As White House Awaits Beijing&#8217;s Call — &#8216;China Needs To Make A Deal With Us&#8217;</a></strong></li>
</ul>
<p><em>Photo: Shutterstock</em></p>


Asia

Equities

Government

Large Cap

Macro Economic Events

Regulations

Sector ETFs

Broad U.S. Equity ETFs

Econ #s

Economics

Federal Reserve

Tech

ETFs

$BTC

ASML

SPDR Dow Jones Industrial Average ETF Trust

JBHT

KLAC

NVDA

iShares PHLX SOX Semiconductor Sector Index Fund

SOXX

Select Sector SPDR-Consumer Discretionary

Nvidia Drags Wall Street Down, Gold Defies Gravity Ahead Of Powell Remarks: What's Driving Markets Wednesday?

<p>Whales with a lot of money to spend have taken a noticeably bullish stance on <strong>Danaher</strong>.</p>
<p>Looking at options history for Danaher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) we detected 8 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 37% of the investors opened trades with bullish expectations and 25% with bearish.</p>
<p>From the overall spotted trades, 2 are puts, for a total amount of $108,275 and 6, calls, for a total amount of $242,410.</p>
<h3>Predicted Price Range</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $175.0 to $210.0 for Danaher over the last 3 months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>In terms of liquidity and interest, the mean open interest for Danaher options trades today is 314.57 with a total volume of 375.00.</p>
<p>In the following chart, we are able to follow the development of volume and open interest of call and put options for Danaher's big money trades within a strike price range of $175.0 to $210.0 over the last 30 days.</p>
<h3>Danaher Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1744657257_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>DHR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$23.9</td>
<td>$23.0</td>
<td>$23.2</td>
<td>$195.00</td>
<td>$67.2K</td>
<td>71</td>
<td align="right">44</td>
</tr>
<tr>
<td>DHR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$4.0</td>
<td>$3.5</td>
<td>$3.4</td>
<td>$175.00</td>
<td>$61.8K</td>
<td>434</td>
<td align="right">200</td>
</tr>
<tr>
<td>DHR</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$33.0</td>
<td>$30.1</td>
<td>$31.7</td>
<td>$180.00</td>
<td>$47.5K</td>
<td>12</td>
<td align="right">0</td>
</tr>
<tr>
<td>DHR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$29.0</td>
<td>$28.7</td>
<td>$29.0</td>
<td>$210.00</td>
<td>$46.3K</td>
<td>1.2K</td>
<td align="right">16</td>
</tr>
<tr>
<td>DHR</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$27.6</td>
<td>$24.5</td>
<td>$25.8</td>
<td>$190.00</td>
<td>$38.7K</td>
<td>25</td>
<td align="right">15</td>
</tr>
</tbody>
</table>
</p>
<h3>About Danaher</h3>
<p>In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.</p>
<h3>Where Is Danaher Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 2,343,628, the DHR's price is up by 1.67%, now at $191.89. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 8 days.</li>
</ul>
<h3>Professional Analyst Ratings for Danaher</h3>
<p>In the last month, 1 experts released ratings on this stock with an average target price of $205.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; Showing optimism, an analyst from Barclays upgrades its rating to Overweight with a revised price target of $205. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Danaher options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.</p>


Options

Smart Money Is Betting Big In DHR Options

WIIM

Danaher shares are trading lower after Barclays cut its price target on the stock from $240 to $205.

<p>Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.</p>
<ul>
<li>B of A Securities analyst Christopher Nardone upgraded the rating for <strong>Levi Strauss &amp; Co.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEVI#NYSE">LEVI</a>) from Neutral to Buy and raised the price target from $17 to $20. Levi Strauss shares closed at $14.93 on Wednesday. <a href="https://www.benzinga.com/quote/levi/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Goldman Sachs analyst Mark Delaney upgraded <strong>Sensata Technologies Holding plc</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ST#NYSE">ST</a>) from Neutral to Buy and lowered the price target from $31 to $27. Sensata shares closed at $20.88 on Wednesday. <a href="https://www.benzinga.com/quote/st/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Oppenheimer analyst Martin Yang upgraded the rating for <strong>Roblox Corporation</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>) from Perform to Outperform and maintained the price target of $70. Roblox shares closed at $57.31 on Wednesday. <a href="https://www.benzinga.com/quote/rblx/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays analyst Luke Sergott upgraded <strong>Danaher Corporation</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) from Equal-Weight to Overweight and lowered the price target from $240 to $205. Danaher shares closed at $191.89 on Wednesday. <a href="https://www.benzinga.com/quote/dhr/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Benchmark analyst Mark Miller upgraded the rating for <strong>Western Digital Corporation</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDC#NASDAQ">WDC</a>) from Hold to Buy and announced a $55 price target. Western Digital shares closed at $36.30 on Wednesday.  <a href="https://www.benzinga.com/quote/wdc/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
<p>Considering buying WDC stock? Here&#8217;s what analysts think: </p>
<p><figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="612" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/10084525/image-66-1024x612.png" alt="" class="wp-image-865891" style="width:561px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/10084525/image-66-1024x612.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/10084525/image-66-300x179.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/10084525/image-66-768x459.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/10084525/image-66.png 1073w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure></p>
<p><strong>Read This Next:</strong></p>
<ul>
<li><strong> <a href="https://www.benzinga.com/25/04/44710375/top-2-materials-stocks-that-may-fall-off-a-cliff-this-quarter">Top 2 Materials Stocks That May Fall Off A Cliff This Quarter</a></strong> </li>
</ul>
<p><em>Photo via Shutterstock</em></p>


Upgrades

Price Target

Pre-Market Outlook

Analyst Ratings

LEVI

RBLX

This Western Digital Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday

<p>Barclays  analyst Luke Sergott   upgrades Danaher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) from Equal-Weight to Overweight and lowers the price target from $240 to $205.</p>


Barclays Upgrades Danaher to Overweight, Lowers Price Target to $205

<p>Investors with a lot of money to spend have taken a bearish stance on <strong>Danaher</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether this is an institution or just a wealthy individual, we don't know. But when something this big happens with DHR, it often means somebody knows something is about to happen.</p>
<p>Today, Benzinga's options scanner spotted 16 options trades for Danaher.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 37% bullish and 50%, bearish.</p>
<p>Out of all of the options we uncovered, 15 are puts, for a total amount of $1,238,077, and there was 1 call, for a total amount of $28,350.</p>
<h3>Projected Price Targets</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $210.0 to $250.0 for Danaher over the last 3 months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Danaher's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Danaher's whale trades within a strike price range from $210.0 to $250.0 in the last 30 days. </p>
<h3>Danaher Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1743606049_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>DHR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$13.9</td>
<td>$13.0</td>
<td>$13.63</td>
<td>$210.00</td>
<td>$138.8K</td>
<td align="right">613</td>
<td>200</td>
</tr>
<tr>
<td>DHR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$13.9</td>
<td>$13.3</td>
<td>$13.3</td>
<td>$210.00</td>
<td>$133.5K</td>
<td align="right">613</td>
<td>100</td>
</tr>
<tr>
<td>DHR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$13.5</td>
<td>$13.0</td>
<td>$13.0</td>
<td>$210.00</td>
<td>$101.4K</td>
<td align="right">613</td>
<td>237</td>
</tr>
<tr>
<td>DHR</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>05/16/25</td>
<td>$12.5</td>
<td>$12.2</td>
<td>$12.34</td>
<td>$210.00</td>
<td>$101.1K</td>
<td align="right">613</td>
<td>1.0K</td>
</tr>
<tr>
<td>DHR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$13.3</td>
<td>$13.0</td>
<td>$13.0</td>
<td>$210.00</td>
<td>$100.1K</td>
<td align="right">613</td>
<td>392</td>
</tr>
</tbody>
</table>
</p>
<h3>About Danaher</h3>
<p>In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.</p>
<p>Following our analysis of the options activities associated with Danaher, we pivot to a closer look at the company's own performance.</p>
<h3>Current Position of Danaher</h3>
<ul>
<li>Currently trading with a volume of 461,040, the DHR's price is up by 0.5%, now at $201.4. </li>
<li>RSI readings suggest the stock is currently may be approaching oversold.</li>
<li>Anticipated earnings release is in 20 days.</li>
</ul>
<h3>What The Experts Say On Danaher</h3>
<p>Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $260.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; In a positive move, an analyst from Stifel has upgraded their rating to Buy and adjusted the price target to $260. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Danaher, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Danaher Unusual Options Activity For April 02

<p><strong>Danaher's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) short percent of float has risen 31.63% since its last report. The company recently reported that it has <strong>8.17 million shares sold short</strong>, which is 1.29% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 1.66 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>List of the most shorted stocks</strong></a></p>
<h3>Danaher Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1742908525_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for Danaher has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.</p>
<h3>Comparing Danaher's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Danaher's peer group average for short interest as a percentage of float is 6.23%, which means the company has <strong>less</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


Short Sellers

Short Ideas

Looking Into Danaher's Recent Short Interest

<p>Deep-pocketed investors have adopted a bullish approach towards Danaher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in DHR usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 30 extraordinary options activities for Danaher. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 43% leaning bullish and 43% bearish. Among these notable options, 22 are puts, totaling $1,409,168, and 8 are calls, amounting to $753,360.</p>
<h3>Expected Price Movements</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $220.0 to $240.0 for Danaher over the recent three months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>In today's trading context, the average open interest for options of Danaher stands at 1035.5, with a total volume reaching 8,001.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Danaher, situated within the strike price corridor from $220.0 to $240.0, throughout the last 30 days.</p>
<h3>Danaher Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1742843737_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>DHR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$8.0</td>
<td>$7.8</td>
<td>$8.0</td>
<td>$220.00</td>
<td>$200.0K</td>
<td>1.4K</td>
<td align="right">753</td>
</tr>
<tr>
<td>DHR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$8.3</td>
<td>$7.9</td>
<td>$8.0</td>
<td>$220.00</td>
<td>$133.6K</td>
<td>1.4K</td>
<td align="right">430</td>
</tr>
<tr>
<td>DHR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$5.1</td>
<td>$4.8</td>
<td>$4.8</td>
<td>$230.00</td>
<td>$107.5K</td>
<td>2.2K</td>
<td align="right">245</td>
</tr>
<tr>
<td>DHR</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>05/16/25</td>
<td>$12.5</td>
<td>$12.1</td>
<td>$12.28</td>
<td>$220.00</td>
<td>$94.5K</td>
<td>771</td>
<td align="right">193</td>
</tr>
<tr>
<td>DHR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$12.5</td>
<td>$12.2</td>
<td>$12.22</td>
<td>$220.00</td>
<td>$94.0K</td>
<td>771</td>
<td align="right">347</td>
</tr>
</tbody>
</table>
</p>
<h3>About Danaher</h3>
<p>In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.</p>
<h3>Where Is Danaher Standing Right Now?</h3>
<ul>
<li>With a trading volume of 1,289,560, the price of DHR is up by 0.23%, reaching $211.84.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 29 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for Danaher</h3>
<p>Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $260.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Stifel upgraded its action to Buy with a price target of $260. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Danaher, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Behind the Scenes of Danaher's Latest Options Trends

<p>Investors with significant funds have taken a bearish position in Danaher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>), a development that retail traders should be aware of.</p>
<p>This was brought to our attention today through our monitoring of publicly accessible options data at Benzinga. The exact nature of these investors remains a mystery, but such a major move in DHR usually indicates foreknowledge of upcoming events.</p>
<p>Today, Benzinga's options scanner identified 24 options transactions for Danaher. This is an unusual occurrence. The sentiment among these large-scale traders is mixed, with 25% being bullish and 54% bearish. Of all the options we discovered, 23 are puts, valued at $2,201,067, and there was a single call, worth $29,316.</p>
<h3>What's The Price Target?</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $185.0 to $230.0 for Danaher over the recent three months. </p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for Danaher's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Danaher's whale activity within a strike price range from $185.0 to $230.0 in the last 30 days. </p>
<h3>Danaher Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1742572848_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>DHR</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$22.3</td>
<td>$21.6</td>
<td>$22.3</td>
<td>$230.00</td>
<td>$153.8K</td>
<td align="right">259</td>
<td align="right">494</td>
</tr>
<tr>
<td>DHR</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$22.7</td>
<td>$22.4</td>
<td>$22.4</td>
<td>$230.00</td>
<td>$147.8K</td>
<td align="right">259</td>
<td align="right">425</td>
</tr>
<tr>
<td>DHR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$23.1</td>
<td>$22.1</td>
<td>$23.2</td>
<td>$230.00</td>
<td>$104.4K</td>
<td align="right">259</td>
<td align="right">539</td>
</tr>
<tr>
<td>DHR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$15.2</td>
<td>$14.4</td>
<td>$15.3</td>
<td>$220.00</td>
<td>$100.9K</td>
<td align="right">663</td>
<td align="right">364</td>
</tr>
<tr>
<td>DHR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$15.0</td>
<td>$13.7</td>
<td>$14.87</td>
<td>$220.00</td>
<td>$100.9K</td>
<td align="right">663</td>
<td align="right">833</td>
</tr>
</tbody>
</table>
</p>
<h3>About Danaher</h3>
<p>In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.</p>
<p>Following our analysis of the options activities associated with Danaher, we pivot to a closer look at the company's own performance.</p>
<h3>Current Position of Danaher</h3>
<ul>
<li>With a trading volume of 1,444,603, the price of DHR is down by -0.49%, reaching $209.22.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 32 days from now.</li>
</ul>
<h3>What The Experts Say On Danaher</h3>
<p>Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $260.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; Showing optimism, an analyst from Stifel upgrades its rating to Buy with a revised price target of $260. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Danaher options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.</p>


Check Out What Whales Are Doing With DHR

Danaher shares are trading higher after Stifel upgraded the stock from Hold to Buy and announced a price target of $260.

<p>Whales with a lot of money to spend have taken a noticeably bearish stance on <strong>Danaher</strong>.</p>
<p>Looking at options history for Danaher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) we detected 10 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 20% of the investors opened trades with bullish expectations and 50% with bearish.</p>
<p>From the overall spotted trades, 8 are puts, for a total amount of $943,019 and 2, calls, for a total amount of $135,156.</p>
<h3>Projected Price Targets</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $185.0 to $220.0 for Danaher over the last 3 months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>In today's trading context, the average open interest for options of Danaher stands at 897.43, with a total volume reaching 1,470.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Danaher, situated within the strike price corridor from $185.0 to $220.0, throughout the last 30 days.</p>
<h3>Danaher Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1741971646_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>DHR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$11.0</td>
<td>$9.9</td>
<td>$11.0</td>
<td>$190.00</td>
<td>$578.7K</td>
<td>391</td>
<td align="right">526</td>
</tr>
<tr>
<td>DHR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$2.85</td>
<td>$2.6</td>
<td>$2.67</td>
<td>$210.00</td>
<td>$106.8K</td>
<td>4.4K</td>
<td align="right">416</td>
</tr>
<tr>
<td>DHR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>04/04/25</td>
<td>$9.7</td>
<td>$8.3</td>
<td>$9.0</td>
<td>$215.00</td>
<td>$81.1K</td>
<td>7</td>
<td align="right">90</td>
</tr>
<tr>
<td>DHR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>09/19/25</td>
<td>$15.4</td>
<td>$15.3</td>
<td>$15.4</td>
<td>$210.00</td>
<td>$73.9K</td>
<td>526</td>
<td align="right">50</td>
</tr>
<tr>
<td>DHR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$12.7</td>
<td>$11.6</td>
<td>$12.7</td>
<td>$210.00</td>
<td>$50.8K</td>
<td>209</td>
<td align="right">40</td>
</tr>
</tbody>
</table>
</p>
<h3>About Danaher</h3>
<p>In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.</p>
<h3>Current Position of Danaher</h3>
<ul>
<li>Trading volume stands at 1,101,906, with DHR's price up by 2.77%, positioned at $209.75.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 39 days.</li>
</ul>
<h3>Professional Analyst Ratings for Danaher</h3>
<p>Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $260.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; In a positive move, an analyst from Stifel has upgraded their rating to Buy and adjusted the price target to $260. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Danaher, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Unpacking the Latest Options Trading Trends in Danaher

<p>Providing a diverse range of perspectives from bullish to bearish, 10 analysts have published ratings on Danaher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) in the last three months.</p>
<p>The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">4</td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts have recently evaluated Danaher and provided 12-month price targets. The average target is $262.5, accompanied by a high estimate of $285.00 and a low estimate of $240.00. A 8.57% drop is evident in the current average compared to the previous average price target of $287.12. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1741960825_0.png" alt="price target chart" /></p>
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
<p>The analysis of recent analyst actions sheds light on the perception of Danaher by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Daniel Arias</td>
<td>Stifel</td>
<td>Announces</td>
<td>Buy</td>
<td>$260.00</td>
<td>-</td>
</tr>
<tr>
<td>Patrick Donnelly</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$265.00</td>
<td>$285.00</td>
</tr>
<tr>
<td>Conor McNamara</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$277.00</td>
<td>$299.00</td>
</tr>
<tr>
<td>Catherine Schulte</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$258.00</td>
<td>$268.00</td>
</tr>
<tr>
<td>Brandon Couillard</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$240.00</td>
<td>$280.00</td>
</tr>
<tr>
<td>Luke Sergott</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$240.00</td>
<td>$275.00</td>
</tr>
<tr>
<td>Tycho Peterson</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Buy</td>
<td>$260.00</td>
<td>$285.00</td>
</tr>
<tr>
<td>Andrew Cooper</td>
<td>Raymond James</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$275.00</td>
<td>$300.00</td>
</tr>
<tr>
<td>Patrick Donnelly</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$285.00</td>
<td>$305.00</td>
</tr>
<tr>
<td>Sung Ji Nam</td>
<td>Scotiabank</td>
<td>Announces</td>
<td>Sector Perform</td>
<td>$265.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Danaher. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Danaher compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts predict movements in price targets, offering estimates for Danaher's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Danaher's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/DHR/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Danaher analyst ratings.</strong></a></p>
<h2>About Danaher</h2>
<p>In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.</p>
<h3>Understanding the Numbers: Danaher's Finances</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.</p>
<p><strong>Revenue Growth:</strong> Danaher's revenue growth over a period of 3 months has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately <strong>2.08%</strong>. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Health Care sector.</p>
<p><strong>Net Margin:</strong> The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of <strong>16.61%,</strong> the company showcases strong profitability and effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> Danaher's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>2.15%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> Danaher's ROA excels beyond industry benchmarks, reaching <strong>1.37%</strong>. This signifies efficient management of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> Danaher's debt-to-equity ratio is below the industry average at <strong>0.35</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<h2>Analyst Ratings: Simplified</h2>
<p>Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.</p>
<p>Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Forecasting The Future: 10 Analyst Projections For Danaher

<p>Stifel  analyst Daniel Arias   upgrades Danaher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) from Hold to Buy and announces $260 price target.</p>


Stifel Upgrades Danaher to Buy, Announces $260 Price Target

Danaher 's Beckman Coulter Announces FDA Clearance Of Its DxC 500i Clinical Analyzer

<p>Danaher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) has outperformed the market over the past 10 years by 2.73% on an annualized basis producing an average annual return of 13.62%. Currently, Danaher has a market capitalization of $149.62 billion. </p>
<p><strong>Buying $100 In DHR:</strong> If an investor had bought $100 of DHR stock 10 years ago, it would be worth <strong>$356.90</strong> today based on a price of $209.35 for DHR at the time of writing.</p>
<h3>Danaher's Performance Over Last 10 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1740603615_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


If You Invested $100 In This Stock 10 Years Ago, You Would Have This Much Today

<p><strong>Dan&nbsp;Loeb‘s&nbsp;Third Point LLC</strong>, which has a varied mix of stock from across the sectors, did some major portfolio restructuring in the <a target="_blank" href="https://www.benzinga.com/topic/dan-loeb" rel="noreferrer noopener">last quarter of 2024</a>.</p>
<p>According to recent 13F filings,&nbsp;reflecting his holding as of Dec. 31, 2024, Loeb slashed a stake in the major Life Sciences Tools &amp; Services company <strong>Danaher Corporation</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) <a target="_blank" href="https://www.sec.gov/Archives/edgar/data/1040273/000108514625001713/xslForm13F_X02/infotable.xml" rel="noreferrer noopener">to </a>1,900,000 from 1,950,000 shares <a target="_blank" href="https://www.sec.gov/Archives/edgar/data/1040273/000108514624005927/xslForm13F_X02/infotable.xml" rel="noreferrer noopener">in </a>the third quarter of 2024, a decline of around 2.5%.</p>
<p>Notably, the investor has been cutting stake in Danaher in the last couple of quarters. Earlier, he held 2,050,000 shares <a target="_blank" href="https://www.sec.gov/Archives/edgar/data/1040273/000108514624004004/xslForm13F_X02/infotable.xml" rel="noreferrer noopener">as </a>of second quarter of 2024 and 2,450,000 shares as <a target="_blank" href="https://www.sec.gov/Archives/edgar/data/1040273/000108514623004511/xslForm13F_X02/infotable.xml" rel="noreferrer noopener">of </a>third quarter of 2023.</p>
<p>Instead, the investor acquired a stake in Danaher&#8217;s major peer <strong>Thermo Fisher Scientific Inc</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TMO#NYSE">TMO</a>), attaining 350,000 shares in the fourth quarter 2024.</p>
<p><strong><em>Read</em></strong><em>: <a target="_blank" href="https://www.benzinga.com/25/02/43861240/repligens-q4-earnings-beat-2025-guidance-highlights-market-growth" rel="noreferrer noopener">Repligen Q4 Earnings Momentum Highlights Market Growth, Issues Strong 2025 Outlook</a></em></p>
<p><strong>DHR Major Events:</strong></p>
<ul>
<li>In January, the company reported weaker-than-expected fourth-quarter earnings, with adjusted earnings per share of $2.14 missing the street view of $2.16 and sales of $6.54 billion (+2%), beating the analyst <a href="https://www.benzinga.com/news/earnings/25/01/43298036/danaher-q4-eps-miss-expectations-amid-diagnostics-segment-lag" target="_blank" rel="noreferrer noopener">consensus estimate of $6.42 billion</a>.</li>
<li>Danaher expects its non-GAAP core revenue to decline by a low-single digit percentage year-over-year in the first quarter. However, it anticipates a 3% year-over-year increase in <a href="https://www.benzinga.com/calendars/guidance" target="_blank" rel="noreferrer noopener">core revenue for the full year of 2025</a>.</li>
<li>Following the earnings release, several analysts cut the price forecast on the stock, with Barclays analyst Luke Sergott lowering the price forecast from $275 to $240 and Wells Fargo analyst Brandon Couillard curtailing the price target from $280 to $240 and <a href="https://www.benzinga.com/25/01/43336758/danaher-analysts-cut-their-forecasts-after-downbeat-earnings" target="_blank" rel="noreferrer noopener">both maintaining an Equal-Weight</a>.</li>
<li>This month, Danaher raised quarterly dividend <a href="https://www.benzinga.com//node/43866316" target="_blank" rel="noreferrer noopener">per share from&nbsp;$0.27&nbsp;to&nbsp;$0.32</a>.</li>
</ul>
<p><strong>TMO Major Events</strong>:</p>
<ul>
<li>Last month, the company reported fourth-quarter adjusted earnings per share of $6.10, beating the street view of $5.94 and sales of $11.395 billion (+5% year over year) outpaced the analyst <a href="https://www.benzinga.com/25/01/43337781/thermo-fisher-q4-earnings-beat-estimates-margin-expands" target="_blank" rel="noreferrer noopener">consensus estimate of $11.277 billion</a>.</li>
<li>Following the earnings release, several analysts raised the price forecast on the stock, with Morgan Stanley analyst Tejas Savant increasing the price target from&nbsp;$647&nbsp;to&nbsp;$678 and Wells Fargo analyst Brandon Couillard upped <a href="https://www.benzinga.com/quote/TMO/analyst-ratings" target="_blank" rel="noreferrer noopener">the price forecast from&nbsp;$660&nbsp;to&nbsp;$680</a>.</li>
<li>This month, Thermo Fisher Scientific raised its quarterly dividend<a href="https://www.benzinga.com//node/43830343" target="_blank" rel="noreferrer noopener"> from $0.39 to $0.43 per share</a>.</li>
<li>Thermo Fisher inked a 10-year VPPA with X-ELIO to enhance renewable energy access in pharmaceutical and healthcare supply chains through the Lorca solar project, set to launch <a href="https://www.benzinga.com/pressreleases/25/02/b43460138/thermo-fisher-scientific-accelerates-100-percent-renewable-electricity-goal-for-european-operation" target="_blank" rel="noreferrer noopener">in early 2026 with three industry partners</a>.</li>
</ul>
<p>Year to date, Danaher shares declined around 10% while Thermo Fisher rose 0.66%, both underperforming the<strong> iShares U.S. Healthcare ETF</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IYH#NYSE">IYH</a>), which gained about 5%&nbsp;over the same time frame.</p>
<p>Also, the companies top peers <strong>Agilent Technologies, Inc.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) fell roughly 0.3% and <strong>IQVIA Holdings, Inc. </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IQV#NYSE">IQV</a>) declined about 1.3% so far this year.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/news/large-cap/25/02/43796723/dan-loebs-third-point-boosts-meta-holdings-now-a-top-4-position" target="_blank" rel="noreferrer noopener">Dan Loeb&#8217;s Third Point Boosts Meta Holdings, Now A Top 4 Position</a></strong></li>
</ul>
<p><em>Photo: Shutterstock</em></p>


iShares Trust Dow Jones US Healthcare Sector Index Fund

Dan Loeb Adjusts Healthcare Holdings: Danaher Stake Trimmed As Thermo Fisher Gains Favor

<p>Investors with a lot of money to spend have taken a bullish stance on <strong>Danaher</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with DHR, it often means somebody knows something is about to happen.</p>
<p>Today, Benzinga's options scanner spotted 13 options trades for <strong>Danaher</strong>.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 53% bullish and 23%, bearish.</p>
<p>Out of all of the options we uncovered, there was 1 put, for a total amount of $34,500, and 12, calls, for a total amount of $814,222.</p>
<h3>Expected Price Movements</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $140.0 to $230.0 for Danaher during the past quarter. </p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for Danaher's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Danaher's whale activity within a strike price range from $140.0 to $230.0 in the last 30 days. </p>
<h3>Danaher Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1740170729_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>DHR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$14.1</td>
<td>$14.1</td>
<td>$14.1</td>
<td>$210.00</td>
<td>$338.7K</td>
<td>468</td>
<td align="right">2</td>
</tr>
<tr>
<td>DHR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/07/25</td>
<td>$5.5</td>
<td>$5.3</td>
<td>$5.3</td>
<td>$210.00</td>
<td>$103.8K</td>
<td>1.5K</td>
<td align="right">196</td>
</tr>
<tr>
<td>DHR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/07/25</td>
<td>$3.8</td>
<td>$3.5</td>
<td>$3.8</td>
<td>$212.50</td>
<td>$66.1K</td>
<td>719</td>
<td align="right">620</td>
</tr>
<tr>
<td>DHR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$10.4</td>
<td>$9.3</td>
<td>$10.0</td>
<td>$210.00</td>
<td>$45.0K</td>
<td>933</td>
<td align="right">0</td>
</tr>
<tr>
<td>DHR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$85.5</td>
<td>$84.4</td>
<td>$85.5</td>
<td>$140.00</td>
<td>$42.7K</td>
<td>6</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
</p>
<h3>About Danaher</h3>
<p>In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.</p>
<p>In light of the recent options history for Danaher, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<h3>Current Position of Danaher</h3>
<ul>
<li>With a trading volume of 3,978,641, the price of DHR is up by 1.46%, reaching $210.98.</li>
<li>Current RSI values indicate that the stock is may be oversold.</li>
<li>Next earnings report is scheduled for 60 days from now.</li>
</ul>
<h3>What Analysts Are Saying About Danaher</h3>
<p>In the last month, 5 experts released ratings on this stock with an average target price of $252.6.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; Consistent in their evaluation, an analyst from Wells Fargo keeps a Equal-Weight rating on Danaher with a target price of $240.<br />
&#x2A; An analyst from Citigroup has decided to maintain their Buy rating on Danaher, which currently sits at a price target of $265.<br />
&#x2A; Consistent in their evaluation, an analyst from Jefferies keeps a Buy rating on Danaher with a target price of $260.<br />
&#x2A; An analyst from Baird has decided to maintain their Outperform rating on Danaher, which currently sits at a price target of $258.<br />
&#x2A; Maintaining their stance, an analyst from Barclays continues to hold a Equal-Weight rating for Danaher, targeting a price of $240. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Danaher with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.</p>


Danaher's Options Frenzy: What You Need to Know

Dividends

Danaher Increases Quarterly Dividend From $0.27 To $0.32

<p><strong>Repligen Corp</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGEN#NASDAQ">RGEN</a>)&nbsp;released its fourth-quarter adjusted EPS of 44 cents on Tuesday, down from 48 cents a year ago <a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">but beating the consensus of 41 cents</a>.</p>
<p>The bioprocessing technology reported sales of $167.55 million, slightly up from $166.6 million a year ago, almost in line with the <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/g43844804/repligen-reports-fourth-quarter-and-full-year-2024-financial-results" rel="noreferrer noopener">consensus of $167.67 million</a>.</p>
<p>Olivier Loeillot, President and Chief Executive Officer of Repligen, said, "During the fourth quarter, we were very encouraged by the continued momentum across our portfolio. Total revenue in the fourth quarter grew 13%, excluding COVID-19, overcoming two points of currency headwind. Total orders outpaced sales by 6%, driven by our Filtration and Analytics franchises&#8230;While we continue to monitor China and emerging biotech,&nbsp;the overall bioprocessing market is returning to growth. Our order momentum during the second half gives us confidence that we can achieve our 2025 guidance."</p>
<p><strong>Guidance:&nbsp;</strong>Repligen expects 2025 sales of $685 million—$710 million, with organic growth of 9.5%—13.5% and non-COVID revenue growth of 10%—14% compared to the consensus of $694.86 million.</p>
<p>The company expects adjusted EPS of $1.67—$1.76 compared to the consensus of $1.73.</p>
<p><strong>William Blair</strong> says Repligen's Q4 results and 2025 outlook confirm that the bioprocessing industry is recovering strongly, with growth expected to return to normal levels next year.</p>
<p>Repligen's guidance reflects strong quarterly momentum, signaling a market recovery.</p>
<p>Compared to peers like <strong>Danaher Corporation</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) and <strong>Avantor Inc</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVTR#NASDAQ">AVTR</a>), which project mid-to-high single-digit growth in bioprocessing, Repligen's outlook highlights its strong product portfolio and customer positioning that have driven consistent above-market growth.</p>
<p>Since Repligen focuses solely on bioprocessing and has minimal exposure to risks in NIH-funded research, academia, or China, analyst Matt Larew believes its guidance is more predictable than competitors with broader market and geographic exposure.</p>
<p><strong>Price Action:</strong> RGEN stock is up 8.16% at $163.03 at the last check Thursday.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/25/02/43853635/hf-sinclair-reports-mixed-q4-results-with-weak-earning-weak-refining-margins-drive-93-drop-in-adjusted-ebitda" target="_blank" rel="noreferrer noopener">HF Sinclair Reports Mixed Q4 Results, Weak Refining Margins Drive 93% Drop In Adjusted EBITDA</a></strong></li>
</ul>
<p><em>Image via Repligen</em></p>


Analyst Color

Earnings

Guidance

Health Care

Movers

General

AVTR

RGEN

Repligen Q4 Earnings Momentum Highlights Market Growth, Issues Strong 2025 Outlook

Press Releases

Beckman Coulter Introduces Cutting-Edge Research Use Only Assays for Neurodegenerative Disease Research

Aldevron Unveils Next-Generation Alchemy™ Cell-Free DNA Technology for Research Grade Applications

Compass Minerals Announces Senior Leadership Team Appointments

Danaher Reports Fourth Quarter and Full Year 2024 Results

TriLink BioTechnologies® and Aldevron Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology

Danaher Increases Quarterly Dividend

Danaher Announces Appointment of Charles Lamanna to Danaher Board

Danaher to Present at TD Cowen Health Care Conference

Beckman Coulter Announces FDA clearance of DxC 500i Clinical Analyzer, an integrated Clinical Chemistry and Immunoassay System

Danaher Schedules First Quarter 2025 Earnings Conference Call

MRVI

MSFT

Agilent Technologies

AbCellera Biologics

Adaptive Biotechnologies Corporation - Common Stock

Adaptive Biotechnologies

Avantor

Azenta

Bio-Rad Laboratories, Inc. Class A Common Stock

Bio-Rad Laboratories

BioLife Solutions

Bruker

Charles River Laboratories International, Inc. Common Stock

Charles River

Evotec SE - American Depositary Shares each representing 1/2 of one ordinary share

Comments

Danaher

Danaher (DHR) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL